2012 Tuberous Sclerosis Complex Clinical Trial Award Program

by: Iola Bonggay

The United States Department of Defense, otherwise known as DOD, is a federal government agency that is generally in-charge of coordinating and supervising all agencies and functions of the government relating directly to national security and the United States armed forces.

The grants and programs of the DOD are all entirely designed to assist in the realization of its overall agency mission which is to "provide the military forces needed to deter war and to protect the security of our country."

In line with this mission, the United States Department of Defense has recently established the 2012 Tuberous Sclerosis Complex Clinical Trial Award Program in an attempt to financially support the studies regarding the promotion innovative research focused on decreasing the clinical impact of tuberous sclerosis complex (TSC).

Initially, the primary objective of the Tuberous Sclerosis Complex Clinical Trial Award Program is to encourage the execution of innovative research studies aimed at understanding the pathogenesis of TSC and ultimately, translate these findings to the care of individuals with TSC.

  (continued...)

2012 Tuberous Sclerosis Complex Clinical Trial Award Program
  Page 2

About The Author Iola Bonggay is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. She also maintains Websites providing resources on community grants and health grants.

Additional Resources

category - Health Grants

Development of Therapeutics and Diagnostics for Biodefense Program
The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

---

Minor Use Minor Species Development of Drugs: Research Project Grant
The National Institutes of Health has partnered with the U.S. Food and Drug Administration (FDA) and the Center for Veterinary Medicine(CVM) in an effort to establish the Minor Use Minor Species Development of Drugs: Research Project Grant.

---

Government Grants Within The United States Health Sector
The health care system in the US is as diverse as it is all-encompassing. A huge number of health care facilities are now owned by private sectors while a huge chunk of health insurance plans are primarily provided by the government in the public sector.

---

Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability Program
In this capacity, the Food and Drug Administration has recently established the Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability Program in an attempt to study the effects of various physicochemical properties of ophthalmic suspensions and emulsions on ocular bioavailability.

---